Robin C Feldman (Robin Feldman)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Health Insurance

Patient Reported

Traumatic Brain Injury

Top Venues

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics

Nature biotechnology

Annals of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Robin C Feldman, Zachary Rosen
NIH Licensing Would Benefit from Free-Market Provisions. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 51 (S2) (2024)
Robin C Feldman, Zachary Rosen
NIH Licensing Would Benefit from Free-Market Provisions. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 51 (S2) (2024)
Robin C Feldman, Zachary Rosen
NIH Licensing Would Benefit from Free-Market Provisions. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 51 (S2) (2024)
Robin C Feldman
Paucity of intellectual property rights information in the US biologics system a decade after passage of the Biosimilars Act. PLoS medicine 21 (4) (2024)
Robin C Feldman
Paucity of intellectual property rights information in the US biologics system a decade after passage of the Biosimilars Act. PLoS medicine 21 (4) (2024)
Robin C Feldman
Paucity of intellectual property rights information in the US biologics system a decade after passage of the Biosimilars Act. PLoS medicine 21 (4) (2024)
Robin C Feldman
Leading with the trailing edge: facilitating patient choice for insulin products. Journal of law and the biosciences 10 (2) (2023)
Robin C Feldman, Natalie Feldman, Enrique Seoane-Vazquez
A Patient Price Guide for Prescription Medication. Annals of internal medicine 175 (6) (2022)
Robin C Feldman, David A Hyman, W Nicholson Price, Mark J Ratain
Negative innovation: when patents are bad for patients. Nature biotechnology 39 (8) (2021)
Garth W Strohbehn, Alec J Kacew, Daniel A Goldstein, Robin C Feldman, Mark J Ratain
Combination therapy patents: a new front in evergreening. Nature biotechnology (2021)